Press release
Preeclampsia Drugs Global Market is Projected to Increase Revenues Growth, Business Insights, Future Demand and Forecast 2024-2033
Preeclampsia Drugs Market
As per the report, the preeclampsia drugs market size has grown rapidly in recent years. It will grow from $1.13 billion in 2023 to $1.25 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The preeclampsia drugs market size is expected to see rapid growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13025&type=smp
Rising Diabetes Cases In Pregnancy Fueling Growth In The Preeclampsia Drug Market
The rise in diabetes cases among pregnant women is expected to propel the growth of the preeclampsia drug market going forward. Diabetes is a metabolic disease that is chronic and characterized by high blood glucose (or blood sugar) levels. Preeclampsia is a harmful pregnancy condition with elevated blood pressure and organ damage. Metformin, a preeclampsia medicine, is widely used in pregnant women with preterm preeclampsia. For instance, in December 2022, according to the National Library of Medicine, a US-based biomedical library and center of biomedical informatics, the total incidence of gestational diabetes mellitus (GDM) was 20,865 cases, an increase of 6.56% in 2022. Therefore, the rise in diabetes cases among pregnant women will drive the preeclampsia drug market.
Leading Companies In The Preeclampsia Medicine Market Pursuing Innovative Drug Solutions
Major companies in the preeclampsia medicine market are focusing on developing cutting-edge drug solutions to boost their market position. For instance, in March 2023, Comanche Biopharma Corp., a US-based biopharmaceutical firm, revealed that the Food and Drug Administration (FDA) has approved an investigational new drug (IND) application for CBP-4888 Comanche's unique siRNA treatment to treat preeclampsia. CBP-4888 is a siRNA therapy given subcutaneously and reduces the synthesis of soluble fms-like tyrosine kinase-1 (sFLT1) in the placenta. The placenta's overproduction of the protein sFLT1, which enters the mother's circulation, is the primary cause of preeclampsia. CBP-4888 can alleviate the symptoms of preeclampsia, such as high blood pressure and organ damage and may allow for the safe extension of pregnancy.
The preeclampsia drugs market covered in this report is segmented -
1) By Type: Mild Preeclampsia; Severe Preeclampsia
2) By Treatment: Medication to Lower Hypertension (B.P); Corticosteroids; Anticonvulsants Medication
3) By Route of Administration: Oral; Parenteral; Other Route of Administration
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacies; Other Distribution Channels
5) By End-User: Hospitals; Specialty Clinics; Diagnostic Centers; Other End-Users
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13025&type=discount
Major players in the preeclampsia drugs market are AbbVie Inc., Pfizer Inc., Johnson & Johnson Co, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi S.A., Celgene Corp, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceuticals Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Siemens Healthcare GmbH, Boehringer Ingelheim Group, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Union Chimique Belge SA, Otsuka Pharmaceutical Co. Ltd., Kyowa Kirin Co Ltd., Mallinckrodt Pharmaceuticals Limited, Comanche Biopharma Corp, Genentech Inc., Diabetomics Inc.
Contents of the report:
1. Executive Summary
2. Preeclampsia Drugs Market Report Structure
3. Preeclampsia Drugs Market Trends And Strategies
4. Preeclampsia Drugs Market - Macro Economic Scenario
5. Preeclampsia Drugs Market Size And Growth
…..
27. Preeclampsia Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/preeclampsia-drugs-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preeclampsia Drugs Global Market is Projected to Increase Revenues Growth, Business Insights, Future Demand and Forecast 2024-2033 here
News-ID: 3619670 • Views: …
More Releases from The Business research company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Preeclampsia
Emerging Preeclampsia Drugs Market Trends: Leading Companies In The Preeclampsia …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Preeclampsia Drugs Market Size Growth Forecast: What to Expect by 2025?
The market size for drugs used in the treatment of preeclampsia has seen a swift escalation in the recent past. This market is projected to soar from a value of $1.25 billion in 2024 to $1.38 billion in…
Preeclampsia Diagnostics Market Current Status and Future Prospects till 2033
Preeclampsia Diagnostics Market size was valued at USD 1.2 Billion in 2024 and is forecasted to grow at a CAGR of 8.5% from 2026 to 2033, reaching USD 2.4 Billion by 2033.
Preeclampsia Diagnostics Market Outlook and Investment Analysis
Q1: What is the current market outlook for Preeclampsia Diagnostics?
The Preeclampsia Diagnostics Market is experiencing growth due to increasing awareness, advancements in diagnostic technologies, and the rising prevalence of preeclampsia globally. Growing demand…
Preeclampsia Drugs Market Report 2025-2034: Industry Overview, Trends, And Forec …
The Preeclampsia Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Preeclampsia Drugs Market Size and Its Estimated Growth Rate?
In recent times, there has been a swift expansion in the market size of drugs for preeclampsia. The market, which is expected…
Preeclampsia Diagnostics Market | Exploring Current Trends and Growth Status for …
Preeclampsia Diagnostics Market size was valued at USD 1.2 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 9.5% from 2024 to 2030.
Preeclampsia Diagnostics Market Outlook and Investment Analysis
What is the current market outlook for Preeclampsia Diagnostics?
The Preeclampsia Diagnostics Market is experiencing growth due to increasing awareness, advancements in diagnostic technologies, and the rising prevalence of preeclampsia globally. Growing demand for…
Preeclampsia Diagnostics Market Forecast Report 2032
Preeclampsia Diagnostics Market By Test Type (Blood Test, Urine Test, Others), By Product & Services (Instruments, Reagents & Consumables, Services), By End-User (Hospitals, Diagnostic Centers, Others) - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032
The preeclampsia diagnostics market [https://www.acutemarketreports.com/report/preeclampsia-diagnostics-market] is expected to grow at a CAGR of 4.1% during the forecast period of 2024 to 2032. This growth will be driven by developments in the discovery of biomarkers, the…
Preeclampsia Market Size, Share, Trends, Report and Forecast 2024-2032
The preeclampsia market size is anticipated to grow at a CAGR of 1.8% during the forecast period of 2024-2032, driven by advancements in early detection and monitoring along with growing hypertension prevalence across major markets.
Preeclampsia: Introduction
Preeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to organ systems, often the kidneys. It usually occurs after 20 weeks of pregnancy in women whose blood pressure had been…
